Patents by Inventor Marc Anthony Yago

Marc Anthony Yago has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSING REGIMEN FOR ANTI-DLL3 AGENTS
    Publication number: 20230174643
    Abstract: The present invention provides a method for the treatment of DLL3-positive cancer or SCLC, comprising administering to a subject in need thereof an anti-DLL3 agent at a dose of between about 0.3 mg to about 100 mg or between about 3 mg to about 200 mg, once every two weeks. Step dosing of the anti-DLL3 agent for the treatment of SCLC is also disclosed.
    Type: Application
    Filed: November 5, 2020
    Publication date: June 8, 2023
    Inventors: Marie-Anne Damiette Smit, Neelesh Soman, Vijay Vishesh Upreti, Mukul Minocha, Michael Liao, Aditya Shetty, Nooshin Hashemi Sadraei, Gataree Ngarmchamnanrith, Marc Anthony Yago
  • DOSAGE REGIMEN FOR ANTI-EGFRVIII AGENTS
    Publication number: 20220411516
    Abstract: The invention provides a method for the treatment of EGFRvIII-positive cancer or glioblastoma, comprising administering to a subject in need thereof an initial dose of between about 15 ?g/day to about 6000 ?g/day of an anti-EGFRvIII agent. Diagnostic methods for assessing EGFRvIII expression are also provided.
    Type: Application
    Filed: November 5, 2020
    Publication date: December 29, 2022
    Applicants: AMGEN INC., AMGEN RESEARCH (MUNICH) GMBH
    Inventors: Johannes Kast, Sabine Karin Stienen, Vijay Upreti, Marc Anthony Yago